Accession Number: | 0000899243-22-021896 |
Date: | 2022-06-08 |
Issuer: | OMEGA THERAPEUTICS, INC. (OMGA) |
Original Submission Date: |
LEVY ELLIOTT M.
C/O OMEGA THERAPEUTICS, INC.
20 ACORN PARK DRIVE
CAMBRIDGE, MA 02140
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTION (RIGHT TO BUY) | 3.31 | 2022-06-08 | deemed execution date | A | 18,118 (a) | 2032-06-07 | common stock 18,118 | $3.31 | 18,118 | direct |
ID | footnote |
---|---|
f1 | the options vest and become exercisable on the earlier of (i) the date of the issuer's next annual meeting of stockholders and (ii) the first anniversary of the date of grant, subject to the reporting person's continued service on the issuer's board of directors through such vesting date. |